IG

Ivan Gergel

Managing Partner and Chief Medical Officer, New Rhein Healthcare Investors LLC.

Philadelphia, Pennsylvania

Invests in

Stages:

Sectors:

Pharmaceuticals

Locations:

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Education

Master of Business Administration - MBA
The Wharton School
(1995 - 1997)
MRCPsych
Royal College of Psychiatrists
(1985 - 1988)
Doctor of Medicine - MD
University of London
(1978 - 1983)

Investments

Corsair Pharma

Total Funding: $23M

Work Experience

2023

Chairman of the Board of Directors
2023

Theranica Bio-Electronics Ltd.

2022

Director Board of Directors
2022

Butterfly Medical

2020

Director Board of Directors
2020

New Rhein Healthcare Investors

2018

Managing Partner and Chief Medical Officer
2018

Neuraptive Therapeutics

2018

Director Board of Directors
2018

Travecta Therapeutics

2021 - 2022

Director Board of Directors
2021 - 2022

Neurotrope Inc.

2018 - 2020

Director Board of Directors
2018 - 2020

Realm Therapeutics, Inc.

2016 - 2019

Director Board of Directors
2016 - 2019

2014 - 2018

Director Board of Directors
2014 - 2018

Nektar Therapeutics

2014 - 2017

Head of Development & Chief Medical Officer
2014 - 2017